LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Hyperglycaemia following immune checkpoint inhibitor therapy—Incidence, aetiology and assessment

Photo by neom from unsplash

We systematically studied the presence of hyperglycaemia during treatment with Immune Checkpoint Inhibitors (ICPI) for cancer, in those with and without diabetes at baseline, and determined the cause of new‐onset… Click to show full abstract

We systematically studied the presence of hyperglycaemia during treatment with Immune Checkpoint Inhibitors (ICPI) for cancer, in those with and without diabetes at baseline, and determined the cause of new‐onset hyperglycaemia,

Keywords: checkpoint inhibitor; immune checkpoint; following immune; hyperglycaemia following; hyperglycaemia

Journal Title: Diabetic Medicine
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.